Member Info for tqhussain

I can see Vortex being sold or floated on to the market, the latter is my gut feeling.

I hope these are not just cheap words and the BOD is working hard to give the SP a bump up.

"We have a well-balanced portfolio across sectors and geographies, with businesses at different stages of their development, and adaptable for a changing sectoral and macro-economic dynamics. Within several of our companies, we are working on substantial liquidity events or routes to exit. ."

Nice to see Q-bot ltd involvement

https://www.gov.uk/government/publications/heat-pump-ready-programme-successful-projects/heat-pump-ready-programme-stream-2-projects#q-bot-ltd

https://www.fogartyinnovation.org/g-tech-builds-on-demand-for-its-groundbreaking-device/

A new device for diagnosing bone fragility invented by the University Hospitals of Geneva (HUG) and the University of Geneva (UNIGE) has been approved for marketing in the European Economic Area and Switzerland. Licensed by the Northern Irish company ProAxsis, it has been launched this summer. The device is based on a new approach to assessing bone quality via blood sampling. This test is much more specific than current techniques and will significantly improve diagnosis and advance the development of new treatments for osteoporosis.

https://www.hug.ch/en/actualite/bone-fragility-european-green-light-marketing-precision-diagnostics

The article is about liver cancer and how the state of Texas is trying to tackle the problem.
I was really just highlighting the point below for those interested in NSCI/Glycotest. It's not new info.

'This study is also conducting phase III validation of two biomarker panels for early HCC detection – GALAD and Glycotest – to see if these offer high sensitivity for early-stage HCC.'

We should know if it the trials have gone well in the coming months.

Fingers crossed.

https://www.frontiersin.org/articles/10.3389/fonc.2022.953933/full

Dr. Amit Singal at UT Southwestern leads the third CAP research project focused on evaluating a blood-based biomarker for risk stratification and early detection of HCC. This study is also conducting phase III validation of two biomarker panels for early HCC detection – GALAD and Glycotest – to see if these offer high sensitivity for early-stage HCC. The hypothesis for this study is that androgens increase risk of HCC and estrogens decrease risk of HCC. Further, this proposal leverages data and samples from THCCC to evaluate the extent to which circulating sex hormones are associated with HCC risk in men and women in a nested case-control study.

I think it was the CE marking for Proaxsis/AZ covid test which was mentioned in the last webinar.

'Continued expansion of Aptamer's partnership with DeepVerge plc has seen the installation of Optimer-enabled Microtox®PD systems at six sites across the UK as part of the Environmental Monitoring for Health Protection (EMHP) programme'

https://www.streetinsider.com/Corporate+News/PDS+Biotechnology+%28PDSB%29+Announces+Independent+Data+Monitoring+Committee+Recommends+VERSATILE-002+Trial+Continuation+without+Modifications/20415699.html

PDSB up 12%

Added more today.

PDSB climbing up again.

Sagetech news: We are proud to announce that SageTech Medical’s innovative waste volatile anaesthetic gas capture device has received the UKCA Mark from the MHRA!

UK Conformity Assessed (UKCA) marking is a mark that indicates conformity with the applicable requirements for products sold within Great Britain.

Thanks to the commitment and hard work of our team, we have been able to reach this significant milestone!

Another ground-breaking solution comes from Q-Bot – who use robots to install underfloor insulation, accessing spaces that would be expensive or impossible to reach with more conventional approaches.

Q-Bot worked with Camden Council to install underfloor insulation in 48 properties. This reduced heat loss by 77% and cold draughts by 32%. Councillor Patricia Callaghan said: What’s not to like about Q-Bot, it’s safe, it’s non-disruptive, it makes people’s houses warmer and it can save on bills.”

https://climatechampions.unfccc.int/uk-social-housing-retrofit-could-help-alleviate-fuel-poverty/

Added a few this morning to take my holding over 53k shares.

Proxasis/AZ covid test CE marking news due.

Glad to hear Sofant is making good progress with its technology.

Is it normal for non listed companies to be doing interviews with proactive or is this a sign of things to come?

Good to see directors participating in the placing.

https://www.youtube.com/watch?v=BOtRrIOcC8g

You can buy lower than placing price now!
£3k added.